Prediction of significant prostate cancer in equivocal MRI lesions: A high-volume international multicenter study. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium.
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...
Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures over ...
TORONTO--(BUSINESS WIRE)--Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during ...
Prostate cancer is the most common cancer in men, and the second most common cancer in the UK. Most prostate cancers are either localised or locally advanced at diagnosis. Localised prostate cancer ...
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment. 1-4 Hyaluronic acid is a ...